V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004956 | 290003625 | 1.66 | 42.9 | Palliative (P) | 2016-12-23 | 2016-12-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022093 | DOCETAXEL |
| 290004957 | 290003626 | null | 68.4 | Curative (C) | 2017-03-08 | 2017-03-21 | OCTREOTIDE | N | Y | 290022099 | ABIRATERONE |
| 290004958 | 290003626 | 1.68 | 71.1 | Curative (C) | 2017-12-16 | 2017-12-29 | CARBOPLATIN | 2 | N | 290022099 | CETUXIMAB + IRINOTECAN + MDG |
| 290004959 | 290007777 | 1.54 | null | Palliative (P) | 2016-11-02 | 2016-11-22 | Capecitabine (21days) + Carboplatin | 02 | N | 290022102 | OCTREOTIDE |
| 290004960 | 290003627 | 1.66 | 0 | null | 2016-05-18 | 2016-05-18 | Capecitabine | 02 | N | 290022105 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004961 | 290003628 | null | 118 | Disease modification (D) | 2015-02-01 | 2015-02-18 | OCTREOTIDE | N | N | 290022106 | CAPECITABINE + RT |
| 290004962 | 290003629 | 1.6 | null | Palliative (P) | null | 2013-05-15 | CARBOPLATIN + FLUOROURACIL | N | N | 290022110 | CISPLATIN + FLUOROURACIL |
| 290004963 | 290003630 | 1.56 | null | null | 2018-10-17 | 2018-11-04 | Carboplatin + Cetux + FU (>Cycle 2) | N | null | 290022112 | PACLITAXEL |
| 290004964 | 290003631 | null | 45.3 | Adjuvant (A) | 2016-06-03 | 2016-06-08 | Carboplatin AUC 6 - 10 | 02 | N | 290022114 | CAPECITABINE + RT |
| 290004965 | 290003632 | null | 115.8 | Curative (C) | 2017-08-17 | 2017-08-17 | FLUOROURACIL | null | Y | 290022116 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004966 | 290003633 | 1.66 | null | Palliative (P) | 2013-05-28 | 2013-05-28 | Carboplatin AUC 6 - 10 | N | N | 290022117 | MITOMYCIN |
| 290004967 | 290003633 | 1.74 | 78.6 | Adjuvant (A) | 2017-10-15 | 2017-10-17 | Fluorouracil + Folinic Acid Weekly | 02 | N | 290022117 | AZACITIDINE |
| 290004968 | 290003634 | 1.8 | 80 | Palliative (P) | 2018-12-27 | 2019-01-02 | Capecitabine | N | N | 290022122 | AZACITIDINE |
| 290004969 | 290003635 | 1.72 | 75 | null | 2016-05-26 | 2016-06-02 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | N | 290022123 | FLUOROURACIL |
| 290004970 | 290003636 | null | null | Curative (C) | 2017-01-29 | 2017-02-04 | Capecitabine | N | N | 290022125 | TRIAL |
| 290004971 | 290003637 | null | null | null | 2016-07-09 | 2016-07-09 | Azacitidine | null | null | 290022126 | FLUOROURACIL |
| 290004972 | 290006580 | 1.81 | 63 | Palliative (P) | 2018-04-24 | 2018-04-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 290022128 | CETUXIMAB |
| 290004973 | 290003638 | null | 90.75 | Palliative (P) | 2016-06-11 | 2016-06-19 | LANREOTIDE | N | N | 290022129 | CAPECITABINE + GEMCITABINE |
| 290004974 | 290003639 | 1.68 | 66.65 | Curative (C) | 2017-08-21 | 2017-09-09 | LANREOTIDE | N | N | 290022130 | CAPECITABINE + RT |
| 290004975 | 290003639 | 1.78 | 95.6 | Disease modification (D) | 2015-04-12 | 2015-04-15 | Irinotecan + Modified De Gramont | N | N | 290022130 | CARBOPLATIN + ETOPOSIDE |
| 290004976 | 290003640 | 1.57 | 72.2 | Disease modification (D) | null | 2017-09-05 | Capecitabine + Cisplatin | N | N | 290022136 | GEMCITABINE |
| 290004977 | 290003641 | 1.64 | 44 | Palliative (P) | 2017-11-30 | 2018-01-02 | CISPLATIN + FLUOROURACIL | N | N | 290022139 | CAPECITABINE + CISPLATIN |
| 290004978 | 290003642 | 1.6 | 77 | Palliative (P) | 2016-06-22 | 2016-07-11 | Trial Unspecified | 02 | null | 290022142 | FLUOROURACIL |
| 290004979 | 290003643 | 1.51 | 50.9 | Curative (C) | 2017-11-11 | 2017-11-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022145 | CAPECITABINE |
| 290004980 | 290006582 | 1.57 | 54 | Palliative (P) | null | 2017-08-21 | Cisplatin +Fluorouracil (3 wk) | null | null | 290022147 | FLUOROURACIL |
| 290004981 | 290003644 | 1.79 | 67.3 | Palliative (P) | 2016-11-02 | 2016-11-29 | CISPLATIN + FLUOROURACIL | N | N | 290022148 | DOCETAXEL |
| 290004982 | 290003645 | 1.52 | 58 | Palliative (P) | 2017-04-18 | 2017-04-25 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290022150 | CISPLATIN + GEMCITABINE |
| 290004983 | 290003646 | 1.64 | 72.5 | Palliative (P) | null | 2018-06-29 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 290022152 | SUNITINIB |
| 290004984 | 290003646 | 1.74 | 72 | Palliative (P) | 2014-03-29 | 2014-03-29 | Bevacizumab | 02 | N | 290022152 | CISPLATIN + FLUOROURACIL |
| 290004985 | 290003647 | 1.69 | null | Curative (C) | 2016-07-15 | 2016-07-15 | CARBOPLATIN + VINORELBINE | N | N | 290022154 | NOT MATCHED |
| 290004986 | 290003647 | null | 96 | Curative (C) | 2017-10-22 | 2017-11-17 | Carboplatin AUC 6 - 10 | 02 | Y | 290022154 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290004987 | 290003647 | null | 83.6 | Palliative (P) | 2015-10-29 | 2015-11-30 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 02 | Y | 290022154 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004988 | 290003648 | 1.68 | 67.65 | Adjuvant (A) | null | 2013-12-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 290022158 | CISPLATIN + GEMCITABINE |
| 290004989 | 290003649 | 1.82 | 97.8 | Curative (C) | 2013-09-03 | 2013-09-28 | Trial Unspecified | N | N | 290022160 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004990 | 290003650 | 1.78 | 65 | Palliative (P) | 2018-08-14 | 2018-08-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290022161 | CARBOPLATIN + ETOPOSIDE |
| 290004991 | 290003651 | 1.68 | 54.4 | Curative (C) | null | 2015-10-13 | FLUOROURACIL + IRINOTECAN | N | N | 290022163 | PLATO TRIAL |
| 290004992 | 290003651 | 1.77 | 60 | Neo-adjuvant (N) | 2016-02-09 | 2016-03-01 | CETUXIMAB + RT | N | Y | 290022163 | CAPECITABINE |
| 290004993 | 290003652 | 1.47 | 63 | Adjuvant (A) | 2017-05-12 | 2017-05-22 | LANREOTIDE | Y | N | 290022168 | CAPECITABINE + RT |
| 290004994 | 290003653 | 1.6 | 58 | Palliative (P) | 2015-10-16 | 2015-11-19 | CETUXIMAB + RT | N | N | 290022169 | CAPECITABINE |
| 290004995 | 290003654 | null | null | Curative (C) | null | 2013-12-02 | Capecitabine | N | N | 290022171 | CAPECITABINE |
| 290004996 | 290003654 | 1.72 | 71.5 | Palliative (P) | 2016-04-30 | 2016-05-12 | Capecitabine + Cisplatin | N | N | 290022171 | ENZALUTAMIDE |
| 290004997 | 290003655 | 1.64 | 97 | null | 2016-03-22 | 2016-04-03 | Y-90 | N | N | 290022174 | CETUXIMAB + RT |
| 290004998 | 290003656 | 0 | 67.6 | Palliative (P) | 2016-03-07 | 2016-03-15 | Capecitabine 35days + RT | 02 | N | 290022176 | CARBO + FLUOROURACIL |
| 290004999 | 290003657 | 1.5 | 61.5 | Palliative (P) | 2015-04-12 | 2015-04-12 | EOX | 2 | N | 290022177 | CETUXIMAB + RT |
| 290005000 | 290003658 | 0 | null | Curative (C) | 2013-05-01 | 2013-05-02 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | null | 290022178 | CAPECITABINE + CISPLATIN |
| 290005001 | 290003659 | 1.68 | 98 | Curative (C) | 2015-06-25 | 2015-07-06 | CARBOPLATIN + FLUOROURACIL | 2 | Y | 290022180 | CAPECITABINE + RT |
| 290005002 | 290003659 | 1.77 | 84 | null | 2015-04-02 | 2015-04-02 | CAPECITABINE + RT | 02 | null | 290022180 | Y-90 |
| 290005003 | 290003660 | 1.63 | 83 | Curative (C) | 2018-01-21 | 2018-02-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022183 | CAPECITABINE + RT |
| 290005004 | 290003661 | 1.6 | 70.5 | Adjuvant (A) | 2016-06-15 | 2016-06-25 | Capecitabine 35days + RT | null | null | 290022184 | PEMBROLIZUMAB |
| 290005005 | 290003662 | 1.73 | 78.6 | Palliative (P) | 2015-02-18 | 2015-02-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022185 | PLATO TRIAL |